Amicus Therapeutics Inc
FOLD
Market Cap$1.83B
Close$
$12.62
106.9% upside
Current Fair Value
106.9% upsideUndervalued by 106.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.83 Billion |
|---|---|
| Enterprise Value | $2.04 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.18 |
| Beta | 0.53 |
| Outstanding Shares | 307,689,207 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -62.12 |
|---|---|
| PEG | 112.51 |
| Price to Sales | 6.1 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.75 |
| Enterprise Value to EBIT | -73.91 |
| Enterprise Value to Net Income | 52 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 2.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Amicus Therapeutics Inc
CEO: John Crowley